Erica J. Rogers - 03 Mar 2022 Form 4 Insider Report for Silk Road Medical Inc

Role
President and CEO, Director
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
03 Mar 2022
Net transactions value
-$110,736
Form type
4
Filing time
07 Mar 2022, 17:56:55 UTC
Previous filing
13 Jan 2022
Next filing
13 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +93,570 +71% $0.000000 225,749 03 Mar 2022 Direct F1
transaction SILK Common Stock Award $0 +23,000 +10% $0.000000 248,749 03 Mar 2022 Direct F1
transaction SILK Common Stock Tax liability $110,736 -3,100 -1.2% $35.72 245,649 03 Mar 2022 Direct F2
holding SILK Common Stock 83,843 03 Mar 2022 Trustees of The Surace/Rogers Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Award $0 +85,320 $0.000000 85,320 03 Mar 2022 Common Stock 85,320 $36.01 Direct F4
transaction SILK Option (right to buy) Award $0 +162,700 $0.000000 162,700 03 Mar 2022 Common Stock 162,700 $36.01 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
F3 These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
F4 One forty-eighth of the shares subject to the option shall vest on April 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.